Cargando…
Anesthesia with ciprofol in cardiac surgery with cardiopulmonary bypass: A case report
BACKGROUND: Ciprofol is a novel agent for intravenous general anesthesia. In February 2022, it was approved by the National Medical Products Administration for general anesthesia induction and maintenance. It has the advantages of fast onset, fast elimination, stable circulation, and few adverse rea...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846984/ https://www.ncbi.nlm.nih.gov/pubmed/36687195 http://dx.doi.org/10.12998/wjcc.v11.i1.157 |